Insider Buy/Sell Details for the Healthcare Sector — February 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1586)
INSMED Inc (INSM)
Flammer Martina M.D. — Chief Medical Officer
Shares
869
Price
$152.44
Total Value
$132.47K
Shares Held After
83,243
% of Holdings
1.0%
GILEAD SCIENCES, INC. (GILD)
O'Day Daniel Patrick — Director
Shares
115,640
Price
$150.00
Total Value
$17.35M
Shares Held After
613,912
% of Holdings
15.9%
CYTOKINETICS INC (CYTK)
Callos Andrew — EVP, Chief Commercial Officer
Shares
15,000
Price
$61.93
Total Value
$928.95K
Shares Held After
50,440
% of Holdings
22.9%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
4,624
Price
$78.94
Total Value
$365.00K
Shares Held After
708,719
% of Holdings
0.6%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
5,376
Price
$78.38
Total Value
$421.37K
Shares Held After
713,343
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
675
Price
$485.52
Total Value
$327.72K
Shares Held After
36,781
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
934
Price
$484.92
Total Value
$452.91K
Shares Held After
37,456
% of Holdings
2.4%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
2,748
Price
$483.92
Total Value
$1.33M
Shares Held After
38,390
% of Holdings
6.7%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,103
Price
$482.57
Total Value
$532.27K
Shares Held After
41,138
% of Holdings
2.6%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
2,363
Price
$481.93
Total Value
$1.14M
Shares Held After
42,241
% of Holdings
5.3%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
477
Price
$480.92
Total Value
$229.40K
Shares Held After
44,604
% of Holdings
1.1%
WEED, INC. (BUDZ)
BREEN NICOLE M — Director
Shares
58,980
Price
$0.04
Total Value
$2.09K
Shares Held After
30,282,988
% of Holdings
0.2%
Adaptive Biotechnologies Corp (ADPT)
PISKEL KYLE — Chief Financial Officer
Shares
2,145
Price
$18.46
Total Value
$39.60K
Shares Held After
216,637
% of Holdings
1.0%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
747
Price
$107.67
Total Value
$80.43K
Shares Held After
128,918
% of Holdings
0.6%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
1,000
Price
$106.60
Total Value
$106.60K
Shares Held After
129,665
% of Holdings
0.8%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
1,500
Price
$104.74
Total Value
$157.12K
Shares Held After
130,665
% of Holdings
1.1%
Solid Biosciences Inc. (SLDB)
Brooks Gabriel — Chief Medical Officer
Shares
12,616
Price
$6.44
Total Value
$81.27K
Shares Held After
84,092
% of Holdings
13.0%
Solid Biosciences Inc. (SLDB)
Tan Kevin — CFO & Treasurer
Shares
14,783
Price
$6.44
Total Value
$95.23K
Shares Held After
94,201
% of Holdings
13.6%
Solid Biosciences Inc. (SLDB)
Ganot Ilan — Director
Shares
7,205
Price
$6.44
Total Value
$46.41K
Shares Held After
25,271
% of Holdings
22.2%
Solid Biosciences Inc. (SLDB)
Howton David T — Chief Operating Officer
Shares
18,894
Price
$6.44
Total Value
$121.71K
Shares Held After
97,859
% of Holdings
16.2%
Solid Biosciences Inc. (SLDB)
Cumbo Alexander — Director
Shares
48,913
Price
$6.44
Total Value
$315.09K
Shares Held After
222,018
% of Holdings
18.1%
STRYKER CORP (SYK)
STRYKER RONDA E — Director
Shares
2,160
Price
$368.56
Total Value
$796.08K
Shares Held After
2,457,331
% of Holdings
0.1%
STRYKER CORP (SYK)
STRYKER RONDA E — Director
Shares
6,783
Price
$367.91
Total Value
$2.50M
Shares Held After
2,459,491
% of Holdings
0.3%
STRYKER CORP (SYK)
STRYKER RONDA E — Director
Shares
4,836
Price
$366.56
Total Value
$1.77M
Shares Held After
2,466,274
% of Holdings
0.2%
STRYKER CORP (SYK)
STRYKER RONDA E — Director
Shares
29,110
Price
$365.57
Total Value
$10.64M
Shares Held After
2,471,110
% of Holdings
1.2%
STRYKER CORP (SYK)
STRYKER RONDA E — Director
Shares
61,956
Price
$364.68
Total Value
$22.59M
Shares Held After
2,500,220
% of Holdings
2.4%
STRYKER CORP (SYK)
STRYKER RONDA E — Director
Shares
20,395
Price
$363.50
Total Value
$7.41M
Shares Held After
2,562,176
% of Holdings
0.8%
STRYKER CORP (SYK)
STRYKER RONDA E — Director
Shares
30,067
Price
$362.69
Total Value
$10.90M
Shares Held After
2,582,571
% of Holdings
1.2%
STRYKER CORP (SYK)
STRYKER RONDA E — Director
Shares
25,220
Price
$361.38
Total Value
$9.11M
Shares Held After
2,612,638
% of Holdings
1.0%
STRYKER CORP (SYK)
STRYKER RONDA E — Director
Shares
40,363
Price
$360.41
Total Value
$14.55M
Shares Held After
2,637,858
% of Holdings
1.5%
STRYKER CORP (SYK)
STRYKER RONDA E — Director
Shares
14,673
Price
$359.48
Total Value
$5.27M
Shares Held After
2,678,221
% of Holdings
0.5%
STRYKER CORP (SYK)
STRYKER RONDA E — Director
Shares
14,437
Price
$358.51
Total Value
$5.18M
Shares Held After
2,692,894
% of Holdings
0.5%
RECURSION PHARMACEUTICALS, INC. (RXRX)
Gibson Christopher — Director
Shares
40,000
Price
$4.12
Total Value
$164.80K
Shares Held After
913,839
% of Holdings
4.2%
Solid Biosciences Inc. (SLDB)
Hanrahan Jessie — Chief Regulatory Officer
Shares
12,348
Price
$6.44
Total Value
$79.54K
Shares Held After
70,327
% of Holdings
14.9%
Solid Biosciences Inc. (SLDB)
Herzich Paul — Chief Technology Officer
Shares
10,905
Price
$6.44
Total Value
$70.25K
Shares Held After
69,067
% of Holdings
13.6%
Taysha Gene Therapies, Inc. (TSHA)
Alam Kamran — CHIEF FINANCIAL OFFICER
Shares
1,655
Price
$4.52
Total Value
$7.48K
Shares Held After
1,442,131
% of Holdings
0.1%
BeOne Medicines Ltd. (ONC)
Lee Chan Henry — SVP, General Counsel
Shares
996
Price
$350.00
Total Value
$348.60K
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
Lee Chan Henry — SVP, General Counsel
Shares
664
Price
$348.79
Total Value
$231.60K
Shares Held After
996
% of Holdings
40.0%
Heartflow, Inc. (HTFL)
Bain Capital Life Sciences Investors, LLC — 10% Owner
Shares
2,000,000
Price
$28.05
Total Value
$56.10M
Shares Held After
10,448,158
% of Holdings
16.1%
Merck & Co., Inc. (MRK)
Davis Robert M — Director
Shares
32,462
Price
$118.35
Total Value
$3.84M
Shares Held After
443,602
% of Holdings
6.8%
Merck & Co., Inc. (MRK)
Davis Robert M — Director
Shares
14,972
Price
$117.38
Total Value
$1.76M
Shares Held After
476,064
% of Holdings
3.0%
Merck & Co., Inc. (MRK)
Li Dean Y — Executive VP & President, MRL
Shares
15,087
Price
$118.77
Total Value
$1.79M
Shares Held After
102,270
% of Holdings
12.9%
Merck & Co., Inc. (MRK)
Litchfield Caroline — EVP & CFO
Shares
41,997
Price
$119.61
Total Value
$5.02M
Shares Held After
90,192
% of Holdings
31.8%
Merck & Co., Inc. (MRK)
Smart Dalton E. III — SVP Fin. - Global Controller
Shares
2,400
Price
$119.67
Total Value
$287.22K
Shares Held After
8,205
% of Holdings
22.6%
Merck & Co., Inc. (MRK)
Smart Dalton E. III — SVP Fin. - Global Controller
Shares
4,000
Price
$119.67
Total Value
$478.70K
Shares Held After
10,605
% of Holdings
27.4%
RAPID MICRO BIOSYSTEMS, INC. (RPID)
Longitude Capital Partners II, LLC — 10% Owner
Shares
49,000
Price
$3.88
Total Value
$190.09K
Shares Held After
0
% of Holdings
100.0%
Ceribell, Inc. (CBLL)
Chao Xingjuan — Director
Shares
23,554
Price
$20.16
Total Value
$474.85K
Shares Held After
727,248
% of Holdings
3.1%
Ceribell, Inc. (CBLL)
Chao Xingjuan — Director
Shares
1,446
Price
$20.16
Total Value
$29.15K
Shares Held After
727,248
% of Holdings
0.2%
Ceribell, Inc. (CBLL)
Chao Xingjuan — Director
Shares
14,000
Price
$20.16
Total Value
$282.24K
Shares Held After
727,248
% of Holdings
1.9%
RESMED INC (RMD)
FARRELL PETER C — Director
Shares
2,000
Price
$251.31
Total Value
$502.62K
Shares Held After
64,773
% of Holdings
3.0%
Showing 1251–1300 of 1586 transactions (page 26 of 32)